The goal of this observational study is to determine the prevalence of left ventricular hypertrophy among patients with chronic kidney disease at Sohag University Hospital and assess the effect of erythropoietin therapy on left ventricular mass and geometry in anemic CKD patients. The main question it aims to answer is: Does erythropoietin therapy mitigate or even reverse LVH and improve cardiac geometry ?
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in LVMI following erythropoietin therapy in anemic CKD patients.
Timeframe: - baseline transthoracic echocardiography will be performed for all group study.